MOLINELLI, Elisa
 Distribuzione geografica
Continente #
NA - Nord America 7.120
AS - Asia 3.308
EU - Europa 3.174
SA - Sud America 687
AF - Africa 238
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 4
Totale 14.537
Nazione #
US - Stati Uniti d'America 6.972
SG - Singapore 1.046
IT - Italia 788
VN - Vietnam 772
CN - Cina 674
RU - Federazione Russa 611
BR - Brasile 543
HK - Hong Kong 328
FR - Francia 273
IE - Irlanda 264
SE - Svezia 245
DE - Germania 231
UA - Ucraina 175
GB - Regno Unito 164
FI - Finlandia 148
IN - India 104
CI - Costa d'Avorio 100
BD - Bangladesh 75
CA - Canada 71
NL - Olanda 59
TR - Turchia 57
ZA - Sudafrica 55
AR - Argentina 51
MX - Messico 49
DK - Danimarca 46
JP - Giappone 43
MA - Marocco 42
IQ - Iraq 34
AT - Austria 32
ES - Italia 32
PL - Polonia 29
EC - Ecuador 27
ID - Indonesia 26
KR - Corea 25
UZ - Uzbekistan 19
BE - Belgio 18
VE - Venezuela 15
CL - Cile 14
CO - Colombia 14
PH - Filippine 14
PK - Pakistan 13
TH - Thailandia 12
LT - Lituania 10
PY - Paraguay 10
CZ - Repubblica Ceca 9
SA - Arabia Saudita 9
EG - Egitto 8
GR - Grecia 8
JM - Giamaica 8
KE - Kenya 8
MY - Malesia 8
TN - Tunisia 8
PE - Perù 7
DZ - Algeria 6
NP - Nepal 6
AU - Australia 5
AZ - Azerbaigian 5
IL - Israele 5
TW - Taiwan 5
PA - Panama 4
PS - Palestinian Territory 4
RS - Serbia 4
SN - Senegal 4
UY - Uruguay 4
AE - Emirati Arabi Uniti 3
BG - Bulgaria 3
CH - Svizzera 3
CR - Costa Rica 3
DO - Repubblica Dominicana 3
EU - Europa 3
HR - Croazia 3
HU - Ungheria 3
JO - Giordania 3
KG - Kirghizistan 3
OM - Oman 3
PT - Portogallo 3
AL - Albania 2
GA - Gabon 2
GE - Georgia 2
KZ - Kazakistan 2
LY - Libia 2
QA - Qatar 2
RO - Romania 2
SM - San Marino 2
AI - Anguilla 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BY - Bielorussia 1
CG - Congo 1
CM - Camerun 1
EE - Estonia 1
GT - Guatemala 1
GY - Guiana 1
HN - Honduras 1
KY - Cayman, isole 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LC - Santa Lucia 1
Totale 14.523
Città #
Ashburn 1.351
Singapore 664
Chandler 620
Dallas 493
San Jose 419
Hong Kong 317
Des Moines 315
Boardman 264
Ho Chi Minh City 258
Dublin 255
Fairfield 233
New York 209
Jacksonville 189
The Dalles 179
Hanoi 177
Council Bluffs 175
Los Angeles 155
Beijing 141
Seattle 119
Lauterbourg 114
Moscow 110
Wilmington 108
Abidjan 99
Houston 99
Munich 92
Woodbridge 92
Helsinki 89
Lawrence 82
Princeton 82
Cambridge 72
Milan 70
Ann Arbor 62
San Mateo 62
Ancona 59
Centro 57
Hefei 54
Buffalo 51
London 51
São Paulo 51
Chicago 49
Da Nang 47
Santa Clara 43
Orem 42
Turin 41
San Diego 40
Haiphong 39
Turku 38
Washington 38
Johannesburg 37
Rome 35
Pune 33
Shanghai 33
Tokyo 31
Brooklyn 30
Guangzhou 29
Boydton 28
Denver 25
Montreal 25
Warsaw 25
Wuhan 25
Chennai 23
Columbus 23
Nuremberg 23
San Francisco 22
Brussels 18
Amsterdam 17
Stockholm 17
Atlanta 16
Manchester 16
Urbisaglia 16
Vienna 16
Frankfurt am Main 15
Hải Dương 15
Phoenix 15
Tolentino 15
Elk Grove Village 14
Marche 14
Miano 14
Toronto 14
Baghdad 13
Rio de Janeiro 13
Tashkent 13
Biên Hòa 12
Piscataway 12
Poplar 12
Salt Lake City 12
Boston 11
Curitiba 11
Mexico City 11
Porto Alegre 11
Kazan' 10
Mumbai 10
Quito 10
Cape Town 9
Charlotte 9
Civitanova Marche 9
Guayaquil 9
Menlo Park 9
Naples 9
Philadelphia 9
Totale 9.369
Nome #
Paraoxonase-2: A potential biomarker for skin cancer aggressiveness 321
Melanoma e tessuto adiposo peritumorale: studio preliminare sul ruolo delle adipocitochine nella caratterizzazione e prognosi di malattia 197
Efficacy and safety of topical resorcinol 15% versus topical clindamycin 1% in the management of mild-to-moderate hidradenitis suppurativa: A retrospective study 190
Characterization and clonal diffusion of ceftaroline non-susceptible mrsa in two hospitals in central Italy 184
The Role of Nutrition in Immune-Mediated, Inflammatory Skin Disease: A Narrative Review 183
A novel approach to manage skin toxicity caused by therapeutic agents targeting epidermal growth factor receptor. 179
Clinical outcomes and feasibility of the multidisciplinary management of patients with psoriatic arthritis: two-year clinical experience of a dermo-rheumatologic clinic 167
Paraoxonase-2 Silencing Enhances Sensitivity of A375 Melanoma Cells to Treatment with Cisplatin 159
Biologic Therapy in Inflammatory and Immunomediated Skin Diseases: Safety Profile 156
Beyond Nicotinamide Metabolism: Potential Role of Nicotinamide N‐Methyltransferase as a Biomarker in Skin Cancers 155
Differential expression of nicotinamide n-methyltransferase in cutaneous keratoacanthoma and squamous cell carcinoma: an immunohistochemical study 154
Oxidative stress and alterations of paraoxonases in atopic dermatitis 154
Involvement of the oral cavity in psoriasis: results of a clinical study 152
Nicotinamide N-methyltransferase gene silencing enhances chemosensitivity of melanoma cell lines 151
Diagnostic and prognostic role of nicotinamide N-methyltransferase in cutaneous malignant melanoma 150
Biologic Therapy in Psoriasis (Part II): Efficacy and Safety of New Treatment Targeting IL23/IL-17 Pathways 149
Global coronavirus pandemic (SARS-CoV-2): Past, present, and future of pediatric dermatology 149
Biologic Therapy in Immune Mediated Inflammatory Disease: Basic Science and Clinical Concepts 147
MiR-146a-5p correlates with clinical efficacy in psoriasis patients treated with the TNF alpha inhibitor Adalimumab 145
Effects of in vivo application of an overnight patch containing Allium cepa, allantoin, and pentaglycan on hypertrophic scars and keloids: Clinical, videocapillaroscopic, and ultrasonographic study 144
Biologic Therapy in Psoriasis: Safety Profile 143
Pseudoxanthoma elasticum and skin: Clinical manifestations, histopathology, pathomechanism, perspectives of treatment 142
Telogen effluvium related to post severe Sars-Cov-2 infection: Clinical aspects and our management experience 139
The effect of low-carbohydrates calorie-restricted diet on visceral adipose tissue and metabolic status in psoriasis patients receiving TNF-alpha inhibitors: results of an open label controlled, prospective, clinical study 139
Alexandrite laser as an adjuvant therapy in the management of mild to moderate hidradenitis suppurativa: A controlled prospective clinical study 139
Bimekizumab: dual inhibition as a promising tool in the management of hidradenitis suppurativa 138
Nicotinamide N-methyltransferase in nonmelanoma skin cancers 138
Differential immunohistochemical expression of paraoxonase-2 in actinic keratosis and squamous cell carcinoma 138
Metabolic Comorbidities and Cardiovascular Disease in Pediatric Psoriasis: A Narrative Review 135
Familial lupus panniculitis: two cases, same diagnosis, what evolution? 135
Baricitinib: The first jak inhibitor approved in europe for the treatment of moderate to severe atopic dermatitis in adult patients 134
Review: A safety profile of dalbavancin for onand off-label utilization 133
Vitiligo, from Pathogenesis to Therapeutic Advances: State of the Art 132
Primary Dermal Melanoma: A Rare Clinicopathological Variant Mimicking Metastatic Melanoma 132
Performance of high-frequency ultrasound in the evaluation of skin involvement in cutaneous chronic graft-versus-host disease: A preliminary report 132
Tetraspanin CD9 Expression Predicts Sentinel Node Status in Patients with Cutaneous Melanoma 130
Management of patients with hidradenitis suppurativa during the COVID-19 pandemic: Risk and benefit of immunomodulatory therapy 129
Coexistence of systemic lupus erythematosus, Hashimoto's thyroiditis, and bilateral breast cancer in the same patient: a random association? 127
Finally, recurrent pyoderma gangrenosum treated with Adalimumab: case report and review of the literature 127
Ingenol mebutate in actinic keratosis: A clinical, videodermoscopic and immunohistochemical study 126
Knockdown of nicotinamide N-methyltransferase suppresses proliferation, migration and chemoresistance of Merkel cell carcinoma cells in vitro 125
Metabolic Comorbidities in Pediatric Atopic Dermatitis: A Narrative Review 125
Immunohistochemical expression of nicotinamide N-methyltransferase in lymph node metastases from cutaneous malignant melanoma 125
Metabolic, pharmacokinetic, and toxicological issues surrounding dapsone 125
Safety and efficacy of vaccines during covid-19 pandemic in patients treated with biological drugs in a dermatological setting 124
Acne agminata in Crohn's disease: A diagnostic and therapeutic challenge case for dermatologists 123
Psoriatic patients treated with secukinumab reach high levels of minimal disease activity: results from the SUPREME study 123
Reticulated acanthoma with sebaceous differentiation 122
Methicillin-resistant Staphylococcus aureus as a cause of chronic wound infections: Alternative strategies for management 120
Efficacy of cathelicidin ll-37 in an mrsa wound infection mouse model 120
The Double-Edged Sword of Oxidative Stress in Skin Damage and Melanoma: From Physiopathology to Therapeutical Approaches 120
Melanoma and subcutaneous adipose tissue: Role of peritumoral adipokines in disease characterization and prognosis 119
Acitretin plus macrolides and acitretin monotherapy in the management of hidradenitis suppurativa 119
Biologic Therapy in Psoriasis (Part I): Efficacy and Safety of Tumor Necrosis Factor- alpha Inhibitors 119
Ixekizumab for treatment of moderate to severe plaque psoriasis: real world clinical experience. 119
Hidradenitis suppurativa in a prepubertal case series: a call for specific guidelines 119
Relapsing acute generalized exanthematous pustolosis: a guess. 118
Biological treatments for pediatric psoriasis: state of the art and future perspectives 116
Prognosis in early stage cutaneous T-cell lymphoma treated with psoralen plus ultraviolet A irradiation and low-dose interferon-α: Long-term efficacy and survival according to conventional and emerging clinical endpoints 116
Kaposi-Juliusberg varicelliform eruption in patient suffering from Darier-White disease: a case report and review of the literature 116
How can I take care of you? The dermatologist meets patients' needs during the COVID-19 pandemic 116
Paraoxonase-2: a novel molecular target to enhance chemosensitivity in melanoma and triple negative breast cancer cells 115
Topical application of fumaric acid esters improves appearance of nail psoriasis 115
The Role of Diet in Children with Psoriasis: Emerging Evidence and Current Issues 114
Efficacy of Pembrolizumab in Advanced Melanoma: A Narrative Review 113
Nicotinamide N-methyltransferase: potential involvement in cutaneous malignant melanoma 113
Renbök phenomenon in a Down syndrome patient with hidradenitis suppurativa and alopecia areata 113
Humoral and cellular immunity after mRNA COVID-19 vaccine in psoriatic patients on biological or immunosuppressive therapy: a real-life experience 111
Nicotinamide N-methyltransferase: a new potential biomarker for cutaneous malignant melanoma 111
Fractionated CO2 Laser in Combination with Topical Tacrolimus for Chronic Alopecia Areata: A Case Series Study 110
The sources of antimicrobial peptides against Gram-positives and Gramnegatives: our research experience 109
Oral oxybutynin chloride therapy in the management of hidradenitis suppurativa: A prospective study 109
CT patterns of interstitial lung disease in patients with plaque psoriasis: a retrospective case series study 109
IL-17, IL-23, and p73 expression in cutaneous melanoma: a pilot study 108
Mycosis Fungoides-like Eruption and Infliximab 108
Time to restart: protocol of resumption of activities of a dermatological clinic of a level II hospital in the COVID-19 era 108
Certolizumab Pegol: A New Therapeutic Approach for Acrodermatitis Continua of Hallopeau 108
Comparison of clinical and ultrasound scores in patients with hidradenitis suppurativa: results from an Italian ultrasound working group 106
The Effect of Dalbavancin in Moderate to Severe Hidradenitis Suppurativa 105
Atypical Scleroderma-like Chronic GVHD in a Liver Transplant Patient, Clinical and MRI Correlations 105
Pyoderma gangrenosum succesfully treated with golimumab: Case report and review of the literature 105
Immunohistochemical analysis of paraoxonase-2 in actinic keratosis and squamous cell carcinoma 105
Immunohistochemical expression of nicotinamide N-methyltransferase in cutaneous basal and squamous cell carcinomas 104
Treatment of Moderate-to-Severe Psoriasis in the Presence of Kaposi's Varicelliform Eruption 104
Tissue Biomarkers Predicting Lymph Node Status in Cutaneous Melanoma 103
Efficacy of oral zinc and nicotinamide as maintenance therapy for mild/moderate hidradenitis suppurativa: A controlled retrospective clinical study 102
New Insight into the Molecular Pathomechanism and Immunomodulatory Treatments of Hidradenitis Suppurativa 101
Successfully and safety use of dupilumab in the management of severe atopic dermatitis and concomitant moderate-to-severe hidradenitis suppurativa 99
Prevention of conjunctivitis in patients with atopic dermatitis undergoing treatment with dupilumab: an Italian single-centre experience 99
Our Experience over 20 Years: Antimicrobial Peptides against Gram Positives, Gram Negatives, and Fungi 99
Vaccines for COVID-19 in patients with atopic dermatitis: Three things every dermatologist should know 98
Topical and Systemic Retinoids in the Management of Hidradenitis Suppurativa: A Comprehensive Literature Review 96
Bimekizumab in hidradenitis suppurativa: a valid and rapid emerging treatment 96
Sneddon-Wilkinson disease and monoclonal gammopathy of undetermined significance in the elderly: Case report 96
Systemic antibiotic therapy in hidradenitis suppurativa: a review on treatment landscape and current issues 95
Circulating tumor DNA-based assessment of molecular residual disease in non-metastatic melanoma 93
Recommendations for dermatologists treating patients with atopic dermatitis during the Covid-19 pandemic: a look into the past for a conscious vaccination management 93
Periodontal Disease: An Oral Manifestation of Psoriasis or an Occasional Finding? 92
Salivary interleukin-1β: Oral inflammatory biomarker in patients with psoriasis. 91
Pharmacodynamics of TNF α inhibitors for the treatment of psoriasis 91
Totale 12.655
Categoria #
all - tutte 71.830
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 71.830


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202159 0 0 0 0 0 0 0 0 0 0 0 59
2021/2022692 16 100 27 12 29 46 25 53 47 28 137 172
2022/20231.897 132 187 122 176 114 474 8 103 381 10 130 60
2023/20241.281 160 24 150 135 165 293 27 71 19 85 16 136
2024/20252.399 315 179 75 37 99 98 234 94 499 168 316 285
2025/20267.101 561 409 548 694 739 489 1.364 599 581 596 249 272
Totale 14.892